BGMS
Bio Green Med Solution, Inc.NASDAQHealthcare$1.00+1.13%ClosedMarket Cap: $2.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.69
P/S
2.98
EV/EBITDA
0.15
DCF Value
$5.29
FCF Yield
-214.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
18.3%
Operating Margin
-1128.1%
Net Margin
-401.3%
ROE
-58.1%
ROA
-36.6%
ROIC
-123.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $81.0K | 21.0% | $-992.0K | $-988.0K | $-1.31 | — |
| Q2 2025 | $0.00 | -Infinity% | $-1.3M | $-1.3M | $-0.84 | — |
| Q1 2025 | $0.00 | NaN% | $-5.0M | $-81.0K | $-0.09 | — |
| Q4 2024 | $0.00 | -Infinity% | $-1.8M | $-3.1M | $-79.20 | — |
| FY 2024 | $43.0K | 100.0% | $-12.0M | $-11.2M | $-501.60 | — |
| Q3 2024 | $10.0K | 100.0% | $-2.2M | $-2.0M | $-218.23 | — |
| Q2 2024 | $4.0K | 100.0% | $-3.6M | $-3.3M | $-433.02 | — |
| Q1 2024 | $29.0K | 93.1% | $-7.3M | $-2.9M | $-544.80 | — |
| Q4 2023 | $31.0K | 74.2% | $-5.8M | $-5.3M | $-1,495.31 | — |
| FY 2023 | $420.0K | 100.0% | $-25.5M | $-22.6M | $-6,420.00 | — |
| Q3 2023 | $16.0K | 100.0% | $-6.4M | $-6.0M | $-1,731.82 | — |
| Q2 2023 | $373.0K | 100.0% | $-5.5M | $-5.4M | $-1,576.91 | — |